Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions

End-stage renal disease patients require peritoneal dialysis (PD) as a life-saving therapy; however, they continue to experience systemic inflammation and increased cardiovascular pathology. These complications can be exacerbated by exposure to PD solutions (PDS) containing glucose. This highlights...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nephrology, dialysis, transplantation
Hauptverfasser:	Kopytina, Valeria, Marchant, Vanessa, Rodrigues-Diez, Raquel, Pascual-Antón, Lucía, Toggweiler, Nora, Strahl, Lisa, Kane, Jamie, Tejera-Muñoz, Antonio, Cortés, Marcelino, Sucunza, David, Vaquero, Juan J, Vervloet, Marc, Piecha, Dorothea, Eringa, Etto C, Ruiz-Ortega, Marta, López-Cabrera, Manuel, González-Mateo, Guadalupe T
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 13.11.2025
Schlagworte:	cardiovascular disease peritoneal dialysis osmotic agent biocompatibility kidney replacement therapy
ISSN:	1460-2385, 1460-2385
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!